A CD8+ T-cell response is critical for a HCC mouse model to be useful in drug screening and evaluation of therapeutic strategies, because CD8+ T cells are critical to tumor growth suppression and prevention of tumor recurrence. Here, CD8A is linked to hepatocellular carcinoma.